Size does not always matter: Ts65Dn Down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal SAG treatment

J Neurosci. 2013 Sep 25;33(39):15408-13. doi: 10.1523/JNEUROSCI.2198-13.2013.

Abstract

Humans with Down syndrome (DS) and Ts65Dn mice both show a reduced volume of the cerebellum due to a significant reduction in the density of granule neurons. Recently, cerebellar hypoplasia in Ts65Dn mice was rescued by a single treatment with SAG, an agonist of the Sonic hedgehog pathway, administered on the day of birth. In addition to normalizing cerebellar morphology, this treatment restored the ability to learn a spatial navigation task, which is associated with hippocampal function. It is not clear to what extent this improved performance results from restoration of the cerebellar architecture or a yet undefined role of Sonic hedgehog (Shh) in perinatal hippocampal development. The absence of a clearly demonstrated deficit in cerebellar function in trisomic mice exacerbates the problem of discerning how SAG acts to improve learning and memory. Here we show that phase reversal adaptation and consolidation of the vestibulo-ocular reflex is significantly impaired in Ts65Dn mice, providing for the first time a precise characterization of cerebellar functional deficits in this murine model of DS. However, these deficits do not benefit from the normalization of cerebellar morphology following treatment with SAG. Together with the previous observation that the synaptic properties of Purkinje cells are also unchanged by SAG treatment, this lack of improvement in a region-specific behavioral assay supports the possibility that a direct effect of Shh pathway stimulation on the hippocampus might explain the benefits of this potential approach to the improvement of cognition in DS.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cerebellum / pathology
  • Cerebellum / physiopathology*
  • Cyclohexylamines / pharmacology
  • Cyclohexylamines / therapeutic use*
  • Disease Models, Animal
  • Down Syndrome / drug therapy*
  • Hedgehog Proteins / agonists
  • Learning / drug effects*
  • Memory / drug effects*
  • Mice
  • Purkinje Cells / pathology
  • Reflex, Vestibulo-Ocular / drug effects
  • Synapses / pathology
  • Thiophenes / pharmacology
  • Thiophenes / therapeutic use*

Substances

  • Cyclohexylamines
  • Hedgehog Proteins
  • SAG compound
  • Shh protein, mouse
  • Thiophenes